Chou Cheng-Yang | Department of Obstetrics and Gynecology, National Cheng Kung University Medical College
スポンサーリンク
概要
- 同名の論文著者
- Department of Obstetrics and Gynecology, National Cheng Kung University Medical Collegeの論文著者
関連著者
-
Hsu Keng-fu
Department Of Obstetrics And Gynecology National Cheng Kung University Medical College
-
Huang Soon-cen
Department Of Obstetrics And Gynecology Chi Mei Foundation Hospital
-
Chou Cheng-Yang
Department of Obstetrics and Gynecology, National Cheng Kung University Medical College
-
CHOU Cheng-Yang
Department of Nuclear Medicine, Medical College, National Cheng Kung University Medical Center
-
Huang Soon-Cen
Department of Obstetrics and Gynecology, National Cheng Kung University Medical College
-
Chou Cheng-yang
Department Of Nuclear Medicine Medical College National Cheng Kung University Medical Center
-
Cheng Ya-Min
Department of Nursing & Department of Obstetrics and Gynecology, College of Medicine, National Cheng
-
Hsu Keng-fu
Department Of Obstetrics And Gynecology College Of Medicine National Cheng Kung University
-
Hsu Ken-Fu
Department of Obstetrics & Gynecology, Institute of Clinical Medicine, National Cheng Kung Universit
-
Shiau Ai-li
Department Of Microbiology And Immunology National Cheng Kung University Medical College
-
Shiau Ai-li
Department Of Microbiology And Immunology National Cheng Kung University Hospital
-
Wu Chao-liang
Department Of Biochemistry And Molecular Biology National Cheng Kung University Medical College
-
Chung Wen-ju
Department Of Obstetrics And Gynecology National Cheng Kung University Medical College
-
Huang Soon-Cen
GYN, National Cheng Kung University, Medical College, Tainan, TAIWAN
-
Chou Cheng-Yang
GYN, National Cheng Kung University, Medical College, Tainan, TAIWAN
-
Tang Ming-Jer
Department of Physiology, College of Medicine, National Cheng Kung University
-
Tang Ming-jer
Department Of Physiology College Of Medicine National Cheng Kung University
著作論文
- P3-IS-16 Increased expression level of squamous cell carcinoma antigen 2 and 1 ratio is associated with poor prognosis in early-stage uterine cervical cancer(Group86 Oncology2,International Session)
- Novel method for preoperative prediction of Gonadotropin releasing hormone agonist (GnRH-a) treatment response in uterine leiomyoma by 3D power Doppler ultrasonography(Oncology 13)
- 6-29.Different tumor vascular pattern evaluated by 3D Power Doppler ultrasonography(Session 8 Reproduction 2)
- Serial follow up of uterine leiomyoma patient receiving GnRH-agonist with 3D power Doppler ultrasonography(Session15 Oncology7)
- Enhanced Polyadenosine Diphosphate-ribosylation of Smooth Muscle Cells in GnRH Agonist-Treated Uterine Leio-myoma(Session6 Oncology6)
- IS-105 Conditionally replicating E1B-deleted adenovirus driven by the squamous cell carcinoma antigen 2 promoter for uterine cervical cancer therapy(Group13 Oncology5,International Session)
- IS-72 Fas Ligand and Procaspase 3 Are Constitutively Expressed in Uterine Myometrium, Up-regulated in Leiomyoma and Down-regulated Following Gonadotropin Releasing Hormone Agonist Treatment